Ken Griffin’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
Ken Griffin's DNTH Position: Q3 2026 in Review
Ken Griffin reduced its Dianthus Therapeutics (DNTH) stake by 35% in Q3 2026, selling an estimated $35.9M and leaving 629,225 shares worth $55.4M. The position accounts for 0.01% of the portfolio, ranked #1461.
Ken Griffin first reported a position in DNTH in Q2 2018 and has held it in 28 quarters since. The position peaked at $135M in Q1 2026. 275 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.
- Ken Griffin held 629,225 shares of Dianthus Therapeutics worth $55.4M as of Q3 2026.
- Ken Griffin sold 345,686 Dianthus Therapeutics shares in Q3 2026, an estimated $35.9M.
- Dianthus Therapeutics made up 0.01% of Ken Griffin's portfolio in Q3 2026, its #1461 holding.
- Ken Griffin first reported a position in Dianthus Therapeutics in Q2 2018 and has held it in 28 quarters since.
- Ken Griffin's Dianthus Therapeutics position peaked at $135M in Q1 2026.
- 275 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.